4th annual IMPACCT: mHealth in Clinical Trials

4th annual IMPACCT: mHealth in Clinical Trials is organized by Hanson Wade and will be held from Jul 16 - 18, 2019 at The Westin Copley Place, Boston, Boston, Massachusetts, United States of America.

Description:
The clinical and digital innovation space continues to undergo huge growth and development, driven by an underlying maturity in implementation examples of digitally-enabled capabilities in clinical RandD, as well as an industry focus on patient-facing approaches.

The IMPACCT: mHealth in Clinical Trials series will again bring together the top clinical and digital leaders for a comprehensive and open discussion on how to support and drive the clinical innovation needed to make trials truly patient-centric, through the use of digital tools.

Join your peers at this collaborative discussion platform that aims to transform the way patient data is collected and utilized, rethink clinical trial methodologies, overcome key implementation challenges and promote patient-centricity in clinical studies with mobile and digital approaches.

Early booking and group discounts apply, start-up and academic rates are available - see the website for details.

Pre-Conference Workshop: (Jul 16, 2019) - 13:00 - 16:00
Bringing Prescription Digital Therapeutics Through Development to Clinical Validation: Focus on the Patient

Building best practices in development and clinical validation of clinician-prescribed digital therapeutics provides many opportunities for novel solutions to unprecedented challenges. This workshop will address rapidly-developing innovative clinical and regulatory efforts to address the fluid nuances inherent in reaching evolving clinical goals in the context of patient-centric approaches.

Key topics to be addressed include:
• Rethinking Clinical Trial Design
 ? Study design to support regulatory pathways for digital therapeutic success
 ? Active control/sham considerations including expectation testing
 ? Advantages to remote access to devices throughout the course of a study
 ? Outcome selection to test transfer of benefit from practice on intervention to recognized cognitive and functional improvements, with emphasis on real world experience, as well as clinical trial data
• Case Studies
 ? Development of control conditions with appropriate expectation and minimal efficacy outcomes
 ? Selective Stimulus Management Engine (SSME™) in ADHD: Targeted treatment development for different disease populations
 ? Development of a disease-specific PRO/COA directed at measuring improvement in cognitive issues inherent in patients with MDD
 ? Commitment to patient and provider experience: Companion Applications
• Future Possibilities
 ? Personalized Digital Therapeutics (patient-based)
 ? Expansion of application of digital treatments to healthy individuals and non-traditional therapeutic indications
 ? Digital therapeutics in the community

Speakers: Amanda Centi, Research Program Manager, Partners Healthcare, Ameya Phadke, Senior Manager, Technology and Digital Partnerships, Chiesi USA, Ching Tian, General Manager, Digital Accelerator, Novartis, Christopher Tarolli, Instructor of Neurology and Fellow, Movement Disorders and Experimental Therapeutics of Neurological Disease, University of Rochester Medical Center, Cindy Geoghegan, Principal, Patient and Partners, and Project Lead, Mobile Clinical Trials: Engaging Patients and Sites Project, Clinical Trials Transformation Initiative (CTTI), Craig Lipset, Head of Clinical Innovation, Pfizer, Deb Norman, Farlow Clinical Operations and Research Manager, Akili Interactive Labs, Elena Izmailova, Co-founder, Strategic Advisory Board Member and Co-Chair of DiME Research Committee, Digital Medicine (DiME) Society, Georgia Mitsi, Senior Director – Search Evaluation, Digital Healthcare, Sunovion Pharmaceuticals, Zachary Kabelac, Senior Researcher, MIT, Gergely Vertes, Solution Accelerator, Wearable for Epilepsy, UCB, Stacey Curtiss, Senior Director and Leader of the Medical Science Liaison Team, Akili Interactive Labs, Lindsey Riley, Associate Director - Research Partnerships, The Michael J. Fox Foundation for Parkinson’s Research, Rasmus Hogreffe, Head of Virtual Clinical Trials, LEO Innovation Lab, Scott Kellogg, Senior VP, Medical Devices, Akili Interactive Labs, Hassan Kadhim, Director, Head of Clinical Trial Business Capabilities, Bristol-Myers Squibb, Jamie Adams, Assistant Professor, Department of Neurology and Center for Health Technology, University of Rochester Medical Center, Jeremy Wyatt, CTO, ActiGraph, Kamal Jethwani, Senior Director, Pivot Labs, Partners Healthcare, Kyle Holen, Head, Development Design Center, AbbVie, Laura Cooke, Executive Director Global Clinical Program Management, Amgen, Layla Rich, Associate Director, Clinical Trial Engagement and Enrollment, Global Clinical Operations, Bristol-Myers Squibb

Time: 8:45 am to 5:00 pm